Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-15-005089
Filing Date
2015-03-24
Accepted
2015-03-24 16:47:33
Documents
1
Period of Report
2015-03-11

Document Format Files

Seq Description Document Type Size
1 rrd423885.html 3  
1 rrd423885.xml 3 4070
  Complete submission text file 0001181431-15-005089.txt   5617
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
SANDELL SCOTT D (Reporting) CIK: 0001237289 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17263 | Film No.: 15722231